Holdings of T. Rowe Price Health Care ETF
T. Rowe Price Exchange-Traded Funds, Inc. · 102 declared positions · as of Mar 31, 2026
Original filing · Net assets 20.3M $ · Ten largest lines: 44.7 % of the equity sleeve
Sector breakdown
- Health care 62.3 %
- Consumer discretionary 1.5 %
- Materials 0.7 %
- Industrials 0.3 %
- Unattributed 35.2 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 99.8 %
- CHF 0.2 %
The quoted currency of each line, as declared.
Country breakdown
- US 92.4 %
- DK 2.0 %
- KY 0.9 %
- IE 0.9 %
- DE 0.8 %
- NL 0.8 %
- CA 0.7 %
- JE 0.5 %
- IT 0.4 %
- CH 0.4 %
- VG 0.2 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | US | 89 | 18.7M $ | 92.40 % |
| 2 | DK | 2 | 400.1K $ | 1.98 % |
| 3 | KY | 1 | 181.2K $ | 0.90 % |
| 4 | IE | 2 | 175.5K $ | 0.87 % |
| 5 | DE | 1 | 162.6K $ | 0.80 % |
| 6 | NL | 1 | 161.1K $ | 0.80 % |
| 7 | CA | 1 | 148.7K $ | 0.74 % |
| 8 | JE | 1 | 93.7K $ | 0.46 % |
| 9 | IT | 1 | 89.5K $ | 0.44 % |
| 10 | CH | 2 | 83.5K $ | 0.41 % |
| 11 | VG | 1 | 39.1K $ | 0.19 % |
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Eli Lilly & Co | 3,189 | 2.9M $ | 14.48 % |
| 2 | UnitedHealth Group Inc | 4,898 | 1.3M $ | 6.54 % |
| 3 | Thermo Fisher Scientific Inc | 1,893 | 930.5K $ | 4.59 % |
| 4 | Gilead Sciences Inc | 6,020 | 839K $ | 4.14 % |
| 5 | Abbott Laboratories | 7,720 | 792.6K $ | 3.91 % |
| 6 | Danaher Corp | 2,918 | 553.3K $ | 2.73 % |
| 7 | Medtronic PLC | 5,245 | 454.5K $ | 2.24 % |
| 8 | Alnylam Pharmaceuticals Inc | 1,262 | 417.6K $ | 2.06 % |
| 9 | Stryker Corp | 1,235 | 405.8K $ | 2.00 % |
| 10 | Dyne Therapeutics Inc | 20,969 | 380.2K $ | 1.88 % |
| 11 | Waters Corp | 1,192 | 355K $ | 1.75 % |
| 12 | Becton Dickinson & Co | 2,202 | 346.2K $ | 1.71 % |
| 13 | Agilent Technologies Inc | 2,996 | 341.5K $ | 1.69 % |
| 14 | Elanco Animal Health Inc | 13,428 | 321.3K $ | 1.59 % |
| 15 | Humana Inc | 1,835 | 318.2K $ | 1.57 % |
| 16 | Cytokinetics Inc | 4,722 | 311.2K $ | 1.54 % |
| 17 | West Pharmaceutical Services Inc | 1,198 | 300.3K $ | 1.48 % |
| 18 | Boston Scientific Corp | 4,745 | 297.7K $ | 1.47 % |
| 19 | Ascendis Pharma A/S | 1,235 | 282.5K $ | 1.39 % |
| 20 | Biogen Inc | 1,390 | 254.8K $ | 1.26 % |
| 21 | Vaxcyte Inc | 4,136 | 240.3K $ | 1.19 % |
| 22 | Immunome Inc | 10,669 | 233.3K $ | 1.15 % |
| 23 | Mettler-Toledo International Inc | 178 | 224.5K $ | 1.11 % |
| 24 | Cencora Inc | 685 | 215.2K $ | 1.06 % |
| 25 | Apellis Pharmaceuticals Inc | 5,162 | 207.7K $ | 1.03 % |
| 26 | Regeneron Pharmaceuticals, Inc. | 267 | 206.3K $ | 1.02 % |
| 27 | Dexcom Inc | 3,251 | 204.2K $ | 1.01 % |
| 28 | CVS Health Corp | 2,698 | 193.8K $ | 0.96 % |
| 29 | MoonLake Immunotherapeutics | 9,719 | 181.2K $ | 0.89 % |
| 30 | Insulet Corp | 803 | 168.5K $ | 0.83 % |
| 31 | Adaptive Biotechnologies Corp | 12,084 | 167.7K $ | 0.83 % |
| 32 | Bicara Therapeutics Inc | 8,310 | 165.3K $ | 0.82 % |
| 33 | BioNTech SE | 1,829 | 162.6K $ | 0.80 % |
| 34 | IMMATICS NV | 16,368 | 161.1K $ | 0.80 % |
| 35 | Repligen Corp | 1,359 | 160.1K $ | 0.79 % |
| 36 | Cooper Cos Inc/The | 2,197 | 157.1K $ | 0.78 % |
| 37 | Shattuck Labs Inc | 24,111 | 155K $ | 0.77 % |
| 38 | IDEXX Laboratories Inc | 266 | 149.5K $ | 0.74 % |
| 39 | Xenon Pharmaceuticals Inc | 2,558 | 148.7K $ | 0.73 % |
| 40 | Sarepta Therapeutics Inc | 6,817 | 148.3K $ | 0.73 % |
| 41 | Bristol-Myers Squibb Co | 2,432 | 147.5K $ | 0.73 % |
| 42 | Molina Healthcare Inc | 1,082 | 144.2K $ | 0.71 % |
| 43 | Apogee Therapeutics Inc | 1,658 | 139.6K $ | 0.69 % |
| 44 | CG oncology Inc | 2,028 | 137.3K $ | 0.68 % |
| 45 | Agios Pharmaceuticals Inc | 3,906 | 132.1K $ | 0.65 % |
| 46 | Incyte Corp | 1,398 | 131.6K $ | 0.65 % |
| 47 | Kymera Therapeutics Inc | 1,497 | 124.7K $ | 0.62 % |
| 48 | Novo Nordisk A/S | 3,200 | 117.6K $ | 0.58 % |
| 49 | Cabaletta Bio Inc | 43,630 | 117.4K $ | 0.58 % |
| 50 | Align Technology Inc | 634 | 108.7K $ | 0.54 % |
| 51 | Alkermes PLC | 3,048 | 107.8K $ | 0.53 % |
| 52 | Rapport Therapeutics Inc | 3,392 | 106.1K $ | 0.52 % |
| 53 | MapLight Therapeutics Inc | 5,110 | 103.9K $ | 0.51 % |
| 54 | AVALO THERAPEUTICS INC | 6,914 | 103.2K $ | 0.51 % |
| 55 | Kodiak Sciences Inc | 2,705 | 103.1K $ | 0.51 % |
| 56 | Erasca Inc | 6,348 | 102.7K $ | 0.51 % |
| 57 | Natera Inc | 504 | 100.8K $ | 0.50 % |
| 58 | Denali Therapeutics Inc | 5,116 | 98.2K $ | 0.48 % |
| 59 | Novocure Ltd | 8,598 | 93.7K $ | 0.46 % |
| 60 | Stevanato Group SpA | 6,509 | 89.5K $ | 0.44 % |
| 61 | Guardant Health Inc | 929 | 85.8K $ | 0.42 % |
| 62 | Arcus Biosciences Inc | 3,833 | 82.8K $ | 0.41 % |
| 63 | Stoke Therapeutics Inc | 2,468 | 80.4K $ | 0.40 % |
| 64 | Amylyx Pharmaceuticals Inc | 5,711 | 79.4K $ | 0.39 % |
| 65 | CENTESSA PHARMACEUTICALS PLC | 1,990 | 79K $ | 0.39 % |
| 66 | Edwards Lifesciences Corp | 971 | 77.8K $ | 0.38 % |
| 67 | Immunocore Holdings PLC | 2,468 | 74.4K $ | 0.37 % |
| 68 | GRAIL Inc | 1,404 | 72.6K $ | 0.36 % |
| 69 | Dianthus Therapeutics Inc | 848 | 71.2K $ | 0.35 % |
| 70 | ICON PLC | 612 | 67.7K $ | 0.33 % |
| 71 | Prime Medicine Inc | 18,451 | 64.2K $ | 0.32 % |
| 72 | Crinetics Pharmaceuticals Inc | 1,758 | 63.9K $ | 0.32 % |
| 73 | Ionis Pharmaceuticals Inc | 850 | 63.8K $ | 0.32 % |
| 74 | Eikon Therapeutics Inc | 5,840 | 61.8K $ | 0.31 % |
| 75 | Intuitive Surgical Inc | 134 | 61.8K $ | 0.30 % |
| 76 | Caris Life Sciences Inc | 3,377 | 60.4K $ | 0.30 % |
| 77 | Travere Therapeutics Inc | 1,982 | 58.9K $ | 0.29 % |
| 78 | GeneDx Holdings Corp | 891 | 57.2K $ | 0.28 % |
| 79 | Disc Medicine Inc | 841 | 53.8K $ | 0.27 % |
| 80 | Relay Therapeutics Inc | 5,205 | 51.8K $ | 0.26 % |
| 81 | Annexon Inc | 9,315 | 51.6K $ | 0.25 % |
| 82 | Ypsomed Holding AG | 142 | 49.8K $ | 0.25 % |
| 83 | Aktis Oncology Inc | 2,721 | 48.7K $ | 0.24 % |
| 84 | Oscar Health Inc | 3,999 | 45.9K $ | 0.23 % |
| 85 | Enliven Therapeutics Inc | 1,135 | 44.5K $ | 0.22 % |
| 86 | Charles River Laboratories International Inc | 252 | 43.5K $ | 0.21 % |
| 87 | Bruker Corp | 1,196 | 43.2K $ | 0.21 % |
| 88 | Biohaven Ltd | 4,623 | 39.1K $ | 0.19 % |
| 89 | PROCEPT BIOROBOTICS CORP | 1,450 | 36.3K $ | 0.18 % |
| 90 | CRISPR Therapeutics AG | 709 | 33.7K $ | 0.17 % |
| 91 | Black Diamond Therapeutics Inc | 15,543 | 33.1K $ | 0.16 % |
| 92 | Bio-Techne Corp | 593 | 31K $ | 0.15 % |
| 93 | Olema Pharmaceuticals Inc | 1,997 | 29.8K $ | 0.15 % |
| 94 | Soleno Therapeutics Inc | 780 | 26.1K $ | 0.13 % |
| 95 | Personalis Inc | 3,980 | 25.4K $ | 0.13 % |
| 96 | Karyopharm Therapeutics Inc | 4,484 | 25K $ | 0.12 % |
| 97 | Janux Therapeutics Inc | 1,455 | 20.2K $ | 0.10 % |
| 98 | Tango Therapeutics Inc | 933 | 19.5K $ | 0.10 % |
| 99 | Schrodinger Inc/United States | 1,662 | 18.9K $ | 0.09 % |
| 100 | Immunovant Inc | 748 | 18.6K $ | 0.09 % |